
Associate Director Forecasting & Modeling
Merck
Summary
This role is part of the U.S. Market Access Contracting Team within Integrated Account Management (IAM) and reports to the Director, Modeling & Forecasting. The Associate Director will lead Purchase-Based Forecasting and Modeling, including quarterly bottom-up Gross-to-Net (GTN) forecasting across 340B, VA/DoD, Hospital & Specialty GPOs, and other evolving sites of care and purchase-based segments.
Job description
The role partners directly with Customer Managers each forecast cycle, combining customer insights, contracting assumptions, market dynamics, and performance trends. It also serves as the financial modeling subject-matter expert, supporting deal evaluation for in-line and launch brands. The role works across Account Management, Strategy, Revenue Forecasting, GMAX, Finance, Analytics, and external partners to ensure contracting strategies are reflected in forecasts and deal models. It also drives operational excellence through AI, standardization, automation, and continuous improvement.
Primary Responsibilities
Purchase-Based Forecasting
- Lead bottom-up, customer-based purchase forecasting with consistent methods, assumptions, and processes across key classes of trade and contracted products.
- Lead the quarterly GTN forecast process with Customer Managers, combining customer insights, contracting assumptions, market dynamics, and performance trends.
- Partner with Strategy, Finance, Revenue Forecasting, GMAX, and other stakeholders to align GTN, volume, revenue, and market access assumptions and surface key drivers, risks, and opportunities.
- Develop and maintain statistical forecasts in R1 (Cloud TM1) that reflect customer dynamics, contracting assumptions, and market trends.
- Monitor actual versus forecast performance, identify variances, risks, and trends, and apply learnings to future cycles.
Purchase-Based Deal Modeling
- Lead purchase-based deal modeling with consistent methods, assumptions, and processes across key classes of trade for contracted products.
- Advise Customer Managers as the financial modeling subject-matter expert for VA/DoD, GPO, 340B, LOP, and other site-of-care contracting opportunities for in-line and launch brands.
- Enhance launch brand modeling so VA/DoD, GPO, 340B, LOP, and other purchase-based contracting opportunities are evaluated consistently.
- Incorporate competitive dynamics and competitor contracting assumptions into deal models and forecasts.
- Partner with MAPS and payer teams on post-deal analytics, comparing actual contract performance with pre-deal expectations and applying learnings to future modeling, forecasting, and contracting decisions.
Operational Excellence
- Drive operational excellence through AI, standardization, simplification, and automation to improve the accuracy, transparency, scalability, and efficiency of forecasting and modeling processes.
- Partner with AI specialists and external partners to automate manual processes and streamline workflows for a growing launch portfolio.
- Standardize data inputs, methodologies, processes, and controls across forecasting and deal modeling to improve consistency and reduce risk.
- Oversee contractor-led operations to ensure pricing, expense, revenue, and other modeling inputs are accurate and consistently applied.
- Coordinate with external partners to maintain accountability and effective execution across forecasting and deal modeling.
Qualifications & Experience
Education Requirement: BA/BS degree or equivalent.
Experience & Skills
- Business Acumen & Domain Expertise: Understands commercial and market access strategy; translates business needs into KPI-tied analytical requirements.
- Knowledge of pharma, oncology, rare disease, or U.S. payer/market access.
- Strategic Partnering: Consultative business partner experience.
- Experience: Data-driven insights in market access, payer or commercial analytics, finance, data science, or pharma/biotech/consulting.
- Analytical & Technical: Skilled in forecast models, scenario analysis, and business cases; strong quantitative skills.
- Collaboration: Proven cross-functional success (Market Access, Finance, Data Science, Analytics, Account Management).
- Leadership & Independence: Proactive, thrives in ambiguity, creates structure, drives execution.
- Communication: Delivers clear, actionable, data-driven insights; strong stakeholder management.
Required Skills
Accountability, Account Management, Analytics Insights, Automation, Bidding Process, Brand Launches, Commercial Contract Management, Contracting Strategies, Contract Management, Contract Performance, Cross-Functional Leadership, Customer-Focused, Demand Forecasting, Disease Awareness, Financial Analysis, Financial Forecasting, Forecasting Models, Launch Excellence, Launch Management, Market Access, Market Research, Relationship Management, Scenario Analysis, Stakeholder Management, Strategic Thinking.
Requirements
- BA/BS degree or equivalent
- Understands commercial and market access strategy; translates business needs into KPI-tied analytical requirements
- Knowledge of pharma, oncology, rare disease, or U.S. payer/market access
- Consultative business partner experience
- Data-driven insights in market access, payer or commercial analytics, finance, data science, or pharma/biotech/consulting
- Skilled in forecast models, scenario analysis, and business cases; strong quantitative skills
- Proven cross-functional success (Market Access, Finance, Data Science, Analytics, Account Management)
- Proactive, thrives in ambiguity, creates structure, drives execution
- Delivers clear, actionable, data-driven insights; strong stakeholder management
- Accountability
- Account Management
- Analytics Insights
- Automation
- Bidding Process
- Brand Launches
- Commercial Contract Management
- Contracting Strategies
- Contract Management
- Contract Performance
- Cross-Functional Leadership
- Customer-Focused
- Demand Forecasting
- Disease Awareness
- Financial Analysis
- Financial Forecasting
- Forecasting Models
- Launch Excellence
- Launch Management
- Market Access
- Market Research
- Relationship Management
- Scenario Analysis
- Stakeholder Management
- Strategic Thinking
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.